DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,060 | -17.4% | 21,212 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $230,153 | +30.7% | 20,458 | +33.8% | 0.00% | 0.0% |
| Q1 2023 | $176,129 | +1.4% | 15,289 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $173,665 | -9.1% | 14,984 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $191,000 | +87.3% | 15,039 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $102,000 | -29.2% | 14,827 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $144,000 | -24.2% | 14,910 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $190,000 | -28.8% | 15,959 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $267,000 | -24.6% | 16,437 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $354,000 | +142.5% | 16,828 | +79.2% | 0.00% | 0.0% |
| Q1 2021 | $146,000 | -16.1% | 9,389 | +13.5% | 0.00% | 0.0% |
| Q4 2020 | $174,000 | – | 8,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |